This information is intended for media professionals and investors

Document Options

Welcome to the UK Medtronic Newsroom. This resource is intended for journalists and investors with an interest in learning more about Medtronic, the global leader in medical technology -- alleviating pain, restoring health and extending life for millions of people around the world.

Renal denervation (Ardian)

Information about renal denervation, an interventional treatment for uncontrolled hypertension, and Ardian, a company acquired by Medtronic in January 2011. Renal denervation has received the CE (Conformité Européene) mark, which is recognized by more than 100 countries worldwide. It is not approved by the U.S. Food and Drug Administration.
Click here to access to the Ardian newsroom.

Breaking News

Jan 9, 2014

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint


Go to news releases >> >>